Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ertapenem MeSH Descriptor Data 2025


MeSH Heading
Ertapenem
Tree Number(s)
D02.065.589.099.124.225
D03.633.100.300.124.225
Unique ID
D000077727
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077727
Scope Note
A carbapenem derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of Gram-positive and Gram-negative bacterial infections including intra-abdominal infections, acute gynecological infections, complicated urinary tract infections, skin infections, and respiratory tract infections. It is also used to prevent infection in colorectal surgery.
Entry Term(s)
Ertapenem Sodium
Invanoz
Invanz
Pharm Action
Anti-Bacterial Agents
Registry Numbers
G32F6EID2H
2T90KE67L0
0
Related Numbers
2T90KE67L0
CAS Type 1 Name
(4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
Public MeSH Note
2019; ERTAPENEM was indexed under BETA-LACTAMS 2006-2018; and under LACTAMS 2002-2005
History Note
2019 (2002)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/07/03
Ertapenem Preferred
Ertapenem Sodium Narrower
Invanoz Narrower
Invanz Narrower
page delivered in 0.147s